Imperative Care Zoom 7X Catheter for Ischemic Stroke Cleared by FDA

July 23, 2025—Imperative Care, Inc. announced the FDA 510(k) clearance of and first patient cases with its Zoom 7X catheter for aspiration thrombectomy procedures in acute ischemic stroke. The device is the latest addition to the company’s comprehensive Zoom stroke system.

According to Imperative Care, the Zoom 7X catheter incorporates the company’s CenTRX technology: a 96º preshaped tip designed to center in the vessel, maximizing clot ingestion with the extra surface area of the asymmetric tip. This feature allows the device to navigate challenging anatomy and self-orient the geometric tip into the optimal position for full clot aspiration, building on the benefits of asymmetric aspiration in stroke.

Jacob Cherian, MD, and Keith Woodward, MD, discussed the device in the company’s press release. Dr. Cherian is with the University of Maryland Medical Center in Baltimore, Maryland, and Dr. Woodward is with Fort Sanders Regional Medical Center in Knoxville, Tennessee.

“I’ve seen significant benefit in using a shaped asymmetric tip for my stroke procedures,” commented Dr. Cherian. “I believe the tip of Zoom 7X allows the catheter to self-orient from within the center of the vessel for enhanced trackability. This capability, along with a full system approach from 0.088-inch intracranial access to complete clot ingestion, has helped further streamline my procedures.”

Dr. Cherian continued, “I’m encouraged to see Imperative Care respond to feedback from the physician community to engineer a solution that I expect will bring notable improvements to procedure efficiency and speed.”

Dr. Woodward added, “Based on my early experience with Zoom 7X, I anticipate this new tip configuration will help reduce the need for extra devices and simplify my thrombectomy procedures, leading to faster access and case times. Having new options to access and navigate challenging anatomy is key to making stroke treatment fast and reliable.”